DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Femhealth Ventures Management LLC
Femhealth Ventures Management LLC
FemHealth Ventures is a venture capital firm that seeks to invest in women
venture manager, reported GAV $32.0M across 2 vehicles
Importance
20
moderate
Active deployment
55
elevated
Emerging
60
high
Completeness
63
high
Freshness
100
high
Research priority
33
moderate
Identity and regulatory footprint
- Headquarters
- unknown
- Office address
- unknown
- Business phone
- 609-450-3493adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Feb 27, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $102Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- info@femhealthventures.comfemhealthventures.compublished by the subject
- business email
- pr@femhealthventures.comfemhealthventures.compublished by the subject
- business phone
- 609-450-3493adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
22 observed deals
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- not stated or not yet read
- Geography
- global
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation
series d plus 100%
Stage at first entry
series d plus 100%
Sectors
unknown 52%Other Health Care 19%Biotechnology 14%Other 10%Pharmaceuticals 5%
lead rate 0%follow-on rate 0%new logos, 12 months 22
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| FemHealth Ventures Fund II LP | Fund | 2024 form d first sale | Fundraising | unknown | unknown | $39.9M | Sep 17, 2025 |
| Femhealth Ventures Fund I LP | Fund | 2021 form d first sale | Mature | $32.0M Mar 20, 2024 | 74 | $11.9M | Oct 4, 2022 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
6 current, 0 departed
Sean Ainsworth
Founder or executiveBiotech CEO
Maneesha Ghiya
Managing partnerManaging Partner
Susanne Seripiero
OtherExecutive Administrator
Katherine Kalin
PartnerFormer McKinsey Partner & Pharma Exec
Maneesha Ghiya
PartnerManager · since May 1, 2021
Sara Crown Star
Venture partnerVenture Partner
Investments on record
22 edges, 21 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
19 relationships from shared deals, counted for the whole firm
Ascension Ventures 2 shared · recurringDelos Advisors, Inc. 1 shared · one timeAvego Management, LLC 1 shared · one timeHemi Ventures, LLC 1 shared · one timeCatalio Capital Management, LP 1 shared · one timeMPM Bioimpact 1 shared · one timeLerer Hippeau Ventures Management, LLC 1 shared · one timeStory Ventures 1 shared · one timeCivilization Ventures Management, LLC 1 shared · one timeShine Capital 1 shared · one timeLightstone Ventures 1 shared · one timeAmoon Ventures Y.SH. Ltd. 1 shared · one timeVivo Capital, LLC 1 shared · one timeU.S. Venture Partners 1 shared · one timeMitsui & Co. Global Investment, Inc. 1 shared · one timeEvidity Capital LLC 1 shared · one timeGilde Healthcare 1 shared · one timeMVM Partners LLP 1 shared · one timeMedtech Venture Partners 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
2 dated events
- Jun 26, 2023Femhealth Ventures Management LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 26, 2023Femhealth Ventures Fund I LP first reported on Form ADV by Femhealth Ventures Management LLC (Venture Capital Fund), GAV $30,172,888Fund first reported on Form ADVFundsFactFemhealth Ventures Fund I LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $32.0M across 2 vehicles
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $32.0M across 1 vehicles
Evidence
41 observations from 3 sources